Status:
TERMINATED
Cognitive Changes With Gabapentin Treatment
Lead Sponsor:
Washington University School of Medicine
Conditions:
Neuralgia Peripheral
Pain
Eligibility:
All Genders
18-85 years
Brief Summary
This is a single-cohort, prospective, observational study evaluating the effects of gabapentin on cognition. The goal of the study is to determine whether there is a measurable change in cognitive fun...
Eligibility Criteria
Inclusion
- Age between 18 and 85
- Diagnosis of neuropathic pain
- Patient report of average daily pain intensity in the last week \>3 on 0-10 Numerical Rating Scale (NRS).
- Able and willing to sign an IRB-approved written informed consent
Exclusion
- Current pregabalin treatment
- Patient has started taking a new pain medication, or has changed their pain medication dose, in the past 4 weeks.
- Treatment with opioids exceeding 60mg MME.
- Severe cognitive impairment that is documented in medical chart.
Key Trial Info
Start Date :
January 10 2020
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
February 18 2021
Estimated Enrollment :
3 Patients enrolled
Trial Details
Trial ID
NCT04106011
Start Date
January 10 2020
End Date
February 18 2021
Last Update
March 1 2021
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Washington University Medical Center/Barnes-Jewish Hospital
St Louis, Missouri, United States, 63110